Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Blossom Street
Boston, MA 02114Phone+1 617-724-1159Fax+1 617-726-3603
Education & Training
- University of MichiganResidency, Radiation Oncology, 2004 - 2009
- University of MichiganInternship, Internal Medicine, 2004 - 2005
- University of Michigan Medical SchoolClass of 2004
Certifications & Licensure
- MA State Medical License 2009 - 2025
- NH State Medical License 2011 - 2025
- ME State Medical License 2020 - 2021
- MI State Medical License 2004 - 2009
- American Board of Radiology Radiation Oncology
Clinical Trials
- MET-PET for Newly Diagnosed Glioblastoma Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 119 citationsPredicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation.Aditya V. Karhade, Quirina C. B. S. Thio, Paul T. Ogink, Christopher M. Bono, Marco Ferrone
Neurosurgery. 2019-10-01 - 43 citationsPhase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Q. Lee, Nancy Wang, Justine V. Cohen
Nature Communications. 2021-10-12 - 80 citationsSingle-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen, Sara M. Tolaney, Nan Lin
Nature Medicine. 2020-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: